PSTI Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 Jul 2022 @ 06:00):

Stats
Tagesvolumen	170 627
Durchschnittsvolumen	0
Marktkapitalisierung	40.85M
EPS	$-0.310 ( Q3 \| 2022-05-09 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.684 (Sector) 42.63 (Industry) 24.32
ATR14	$0.104 (10.40%)

AADI -2.86%

ABCL -2.15%

ABCM 0.04%

ABEO -2.99%

ABIO 2.29%

ABOS -4.46%

ABSI -3.29%

ABUS -0.65%

ABVX -3.34%

ACAD -1.76%

ACER -17.95%

ACET -2.00%

ACGN 1.29%

ACHL 1.43%

ACHV -1.90%

ACIU -3.37%

ACLX -4.07%

ACRV -3.19%

ACST -3.13%

ACXP -4.82%

ADAG -3.08%

ADAP -1.67%

ADGI 0.87%

ADIL -0.87%

ADMA 0.00%

ADPT 3.04%

ADTX 1.13%

ADVM 1.02%

ADXN -1.60%

AEON 5.94%

AEZS 0.22%

AFMD -3.54%

AGEN -2.36%

AGIO -1.19%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA -5.20%

AKRO -1.47%

AKTX -25.54%

AKUS 0.00%

ALBO 0.00%

ALDX 1.22%

ALEC -5.01%

ALGS -6.06%

ALKS -1.83%

ALLK -1.67%

ALLO -8.05%

ALLR -34.80%

ALNA 3.16%

ALNY 7.74%

ALPN 0.02%

ALPX 0.00%

ALRN -1.64%

ALT 3.78%

ALVR -1.01%

ALXN 0.00%

ALXO 0.31%

ALZN -2.08%

AMRN 2.72%

AMTI -3.13%

ANAB -0.83%

ANEB 4.87%

ANGN 0.00%

ANIX -1.20%

ANL -3.22%

ANNX -3.98%

ANPC -3.15%

APGE -3.92%

APGN 8.48%

APGNW 30.65%

APLM -3.77%

APLS 5.15%

APLT -4.10%

APM 1.06%

APOP 0.38%

APRE 0.24%

APTO -1.43%

APTX 3.17%

APVO -6.12%

ARAV -13.39%

ARCT -3.88%

ARDS 2.28%

ARDX -3.68%

ARGX 2.49%

ARNA 0.00%

ARPO -0.90%

ARQT 8.11%

ARTL 11.29%

ARTLW 0.00%

ARVN -2.04%

ARWR -1.36%

ASLN -2.08%

ASMB -1.91%

ASND 4.95%

ATAI -3.57%

ATHA -7.59%

ATHE -0.83%

ATHX -33.50%

ATNF -0.66%

ATOS -3.74%

ATRA -6.10%

ATXI -2.72%

ATXS -1.74%

AUPH -1.59%

AURA -4.22%

AUTL -6.45%

AVBP -2.13%

AVEO 0.00%

AVIR -1.72%

AVRO -1.41%

AVTE -3.33%

AVTX 3.46%

AVXL -3.80%

AXLA 0.00%

AXSM 0.65%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 1.65%

BCAB -1.92%

BCDA 3.53%

BCDAW -39.75%

BCEL 0.00%

BCLI 3.13%

BCRX -3.03%

BCTX -13.88%

BCTXW -4.44%

BCYC -2.58%

BDRX -2.01%

BDTX -3.89%

BEAM -2.34%

BFRA -2.91%

BGNE -5.13%

BIOR -2.10%

BIVI -5.32%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -5.71%

BLTE -0.27%

BLU 0.03%

BLUE -7.08%

BMEA -6.13%

BMRN -0.20%

BNOX -9.25%

BNTC 0.00%

BNTX -2.57%

BOLD -18.11%

BOLT 0.18%

BPMC 0.42%

BPTH 0.48%

BPTS -13.47%

BRNS 0.74%

BRTX 2.91%

BTAI -0.84%

BTTX 1.35%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI -5.22%

CABA -13.47%

CADL -8.13%

CALA 0.00%

CALC 0.00%

CALT -1.18%

CAPR -3.13%

CARA -2.56%

CARM 2.68%

CASI -4.74%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -5.86%

CCCC 0.00%

CCXI 0.00%

CDAK 0.00%

CDIO -8.01%

CDIOW 24.00%

CDMO -1.53%

CDMOP 0.04%

CDT -15.17%

CDTTW -39.60%

CDTX 5.75%

CDXC -4.31%

CDXS -3.33%

CELC -1.02%

CELU -2.60%

CELUW 11.80%

CERC -1.68%

CERE -4.49%

CERO -14.81%

CEROW 0.60%

CFRX -27.95%

CGEM -5.47%

CGEN -3.21%

CGON -1.47%

CGTX -4.86%

CHMA -6.00%

CHRS -3.07%

CINC 0.00%

CING -3.46%

CINGW 34.95%

CKPT 0.48%

CLBS -16.75%

CLDX 0.11%

CLGN 0.59%

CLLS 1.05%

CLNN -5.91%

CLNNW 0.00%

CLRB -5.59%

CLSD 15.74%

CLSN -0.68%

CLVS 0.00%

CMMB 2.45%

CMND -7.46%

CMPI 0.00%

CMPX -4.50%

CMRA 0.00%

CMRAW 33.33%

CMRX 2.05%

CNCE 0.00%

CNSP 27.35%

CNST 0.00%

CNTA 0.00%

CNTB -3.62%

CNTX 0.46%

COCP -7.20%

COEPW 32.45%

COGT -6.41%

CORT -0.65%

COYA 4.24%

CPRX -1.56%

CRBP 1.93%

CRBU -5.88%

CRDF -4.24%

CRGX -4.30%

CRIS -4.39%

CRNX -1.73%

CRSP -3.43%

CRTX 2.63%

CRVO 0.00%

CRVS -2.73%

CSBR -1.59%

CTCX -11.35%

CTIC 0.06%

CTMX -9.02%

CTNM 3.86%

CTXR 5.10%

CUE -1.70%

CVAC 2.02%

CVKD -2.39%

CWBR 2.80%

CYAD -12.96%

CYCC -4.79%

CYCCP 5.49%

CYCN 5.02%

CYT -2.27%

CYTK -1.91%

CYTO -6.78%

DARE -2.35%

DAWN -0.96%

DBTX -0.81%

DBVT 0.91%

DFFN 10.28%

DICE 0.06%

DMAC 1.80%

DNLI -2.27%

DNTH -5.02%

DOMH 2.16%

DRMA -6.21%

DRMAW -1.25%

DRNA 0.00%

DRTS -1.82%

DRTSW 0.00%

DRUG 5.61%

DSGN -1.49%

DTIL 0.95%

DYAI -3.13%

EARS -1.77%

EDIT -2.17%

EDSA -3.71%

EFTR -1.06%

EFTRW 145.45%

EIGR -9.21%

ELAB -1.03%

ELDN -8.81%

ELEV -1.63%

ELOX -7.14%

ELTX -4.76%

ELVN -1.69%

ELYM -5.28%

ENGN -0.37%

ENGNW 18.81%

ENLV -3.55%

ENOB 1.79%

ENSC -3.98%

ENTA 0.25%

ENTO 1.69%

ENTX -9.22%

ENVB -7.29%

EPIX 0.00%

EPRX -2.97%

EPZM 0.00%

EQ 0.46%

EQRX -2.09%

EQRXW 0.00%

ERAS -3.70%

ERNA -1.64%

ERYP 1.30%

ESLA -0.65%

ESLAW 87.05%

ETNB -6.98%

ETON -1.20%

ETTX 0.00%

EVAX 6.44%

EVGN 0.58%

EVLO 0.00%

EWTX 4.07%

EXAI 0.95%

EXEL -0.27%

EYEG 0.04%

EYEN -2.23%

EYPT -3.05%

FATE -3.13%

FBIO -0.59%

FBIOP 0.32%

FBLG 0.00%

FBRX -6.12%

FDMT -5.38%

FENC -2.36%

FGEN -2.50%

FHTX -1.50%

FIXX 0.77%

FMTX 0.00%

FNCH 8.87%

FOLD -1.30%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE -2.26%

FULC -5.68%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT 4.69%

GANX 0.78%

GBIO 1.43%

GBT 0.01%

GDTC -1.45%

GERN -1.53%

GHRS 0.84%

GLMD -2.79%

GLPG -2.10%

GLSI -0.77%

GLTO -6.44%

GLUE -0.52%

GLYC 25.28%

GMAB -0.15%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -2.81%

GNLX -0.88%

GNPX 0.99%

GNTA 3.94%

GOSS 22.26%

GOVX -27.39%

GOVXW -49.04%

GPCR -8.52%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -3.41%

GRTX 12.03%

GTHX -0.90%

GUTS -9.22%

GXGXW 41.67%

GYRE -3.78%

HALO 0.65%

HARP 0.09%

HCWB -1.65%

HEPA 2.80%

HGEN -84.62%

HILS 5.66%

HLVX -2.68%

HOOK 0.30%

HOTH -4.46%

HOWL -10.34%

HRMY -0.07%

HRTX -4.09%

HSTO 0.00%

HUMA -3.33%

HUMAW 1.27%

IBRX -0.95%

ICCC 0.22%

ICPT 0.21%

ICU -19.90%

ICUCW -13.76%

ICVX -0.91%

IDRA -23.04%

IDYA -2.38%

IFRX -2.99%

IGMS -6.44%

IKNA 0.00%

IKT 0.40%

IMAB 0.00%

IMCR -1.09%

IMGN 0.02%

IMGO 0.00%

IMMP -1.13%

IMMX 1.75%

IMNM -3.35%

IMNN 2.34%

IMPL -27.27%

IMRA 15.96%

IMRN 0.00%

IMRX -4.03%

IMTX -1.64%

IMTXW 6.00%

IMUX -1.82%

IMV 0.00%

IMVT -0.29%

INAB 1.54%

INBX -2.46%

INCY -1.02%

INDP -1.80%

INFI -52.38%

INKT -1.11%

INM -6.35%

INMB -5.05%

INO -3.39%

INSM 1.87%

INTS 0.20%

INVA 0.88%

INZY -2.46%

IOBT 6.72%

IONS 5.19%

IOVA 3.55%

IPA 0.00%

IPHA -1.72%

IPSC -4.48%

IRON -1.04%

ISEE 0.38%

ITOS -1.81%

ITRM 3.42%

IVA 6.96%

IVVD -4.72%

JAGX 0.53%

JANX -4.05%

JAZZ -1.59%

JNCE 0.00%

JSPR -5.33%

JSPRW -16.18%

JUNS 0.00%

JUNSW 0.00%

KA -13.66%

KALV -1.45%

KDNY 0.22%

KMPH -0.34%

KNSA 0.53%

KNTE -0.38%

KOD -7.33%

KPRX 2.21%

KPTI -0.91%

KRBP -10.00%

KRON -6.43%

KROS -1.79%

KRRO -4.81%

KRTX 0.03%

KRYS 1.37%

KTRA 13.76%

KTTA 8.16%

KTTAW 0.92%

KURA -2.80%

KYMR -0.95%

KYTX -1.90%

KZIA -12.30%

KZR 0.97%

LABP 0.57%

LBPH -2.31%

LBPS 0.00%

LBPSW 14.81%

LEGN 1.00%

LENZ -2.43%

LEXX -2.26%

LEXXW -14.63%

LGND -1.33%

LGNDV 0.00%

LGVN -2.08%

LIAN -8.28%

LIFE 2.70%

LIPO -23.38%

LIXT 0.77%

LIXTW -42.57%

LJPC -0.32%

LMNL 0.12%

LOGC 2.68%

LPCN -12.37%

LPTX -3.19%

LQDA -2.54%

LRMR -3.50%

LSTA 3.21%

LTRN 2.56%

LUMO -1.32%

LVTX 3.19%

LXEO -0.76%

LXRX -6.08%

LYEL -3.77%

LYRA -1.79%

MACK 0.10%

MBIO -12.31%

MBRX -0.71%

MCRB -1.11%

MDGL -1.39%

MDNA -13.16%

MDWD 0.55%

MDXG -0.15%

MEIP 2.88%

MESO -0.59%

MGNX -4.67%

MGTA -7.74%

MGTX -1.17%

MGX 3.61%

MIRM -4.91%

MIRO 0.59%

MIST -7.19%

MITO 0.00%

MLEC 7.41%

MLECW 23.81%

MLND -5.36%

MLTX 2.56%

MLYS -3.64%

MNKD -3.50%

MNMD -4.20%

MNOV 2.16%

MNPR 2.63%

MOLN 0.97%

MOR -1.71%

MORF 6.79%

MREO -6.91%

MRKR -1.49%

MRNA 0.44%

MRNS -0.73%

MRSN -4.98%

MRTX -0.17%

MRUS -0.23%

MRVI -2.83%

MTCR -1.29%

MTEM -2.88%

MTP -18.50%

MURA 0.31%

MYMD -1.60%

NAMS 0.20%

NAMSW 0.43%

NAUT 0.67%

NBRV 0.71%

NBSE -1.56%

NBTX 11.93%

NCNA -5.00%

NERV -2.15%

NEXI -1.06%

NGM -1.28%

NGNE -2.05%

NKGN 0.00%

NKGNW 8.00%

NKTR -8.55%

NKTX 9.46%

NLSP -7.12%

NLSPW 26.67%

NMRA -7.89%

NMTR -42.97%

NOVN -24.84%

NRBO 4.41%

NRIX -1.09%

NRSN 1.06%

NRSNW 0.00%

NRXP 0.75%

NRXPW 27.78%

NRXS -2.73%

NTBL -11.13%

NTEC -12.45%

NTHI 0.00%

NTLA -4.00%

NTRBW -31.07%

NUVL -0.30%

NVAX -0.14%

NVCT -1.39%

NVIV -34.28%

NXTC 1.19%

NYMX -0.05%

OABI -6.65%

OABIW -10.06%

OBIO -0.58%

OBSV 0.00%

OCEA 2.16%

OCGN -6.35%

OCS -0.30%

OCUL 0.46%

OCUP -4.38%

ODT -4.27%

OKYO -4.13%

OLMA -1.26%

OMER -4.77%

OMGA -0.83%

ONCO -2.22%

ONCR -3.08%

ONCS 31.87%

ONCT -1.87%

ONCY 0.00%

ONTX -0.47%

ONVO -5.06%

OPNT 0.00%

OPT -1.03%

ORGS -1.66%

ORIC -5.73%

ORMP 0.45%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -3.10%

OVID -11.39%

OYST 0.00%

PALI -3.25%

PASG 0.22%

PBLA 0.00%

PBM -4.22%

PBYI 1.37%

PCSA 6.92%

PCVX -1.69%

PDSB 10.49%

PEPG -6.00%

PGEN 3.73%

PHAR -6.99%

PHAS 0.00%

PHAT -4.62%

PHIO 2.30%

PHIOW 36.47%

PHVS 7.54%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -3.79%

PLUR -5.45%

PMN -5.66%

PMVP -0.59%

PNT 0.16%

PPBT -7.68%

PRAX -6.28%

PRDS 0.93%

PRLD -3.56%

PROG -3.47%

PROK -3.46%

PRQR 0.61%

PRTA -3.84%

PRTC -0.08%

PRTG -5.03%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV 1.86%

PSTX -6.18%

PTCT -1.73%

PTE -0.82%

PTGX -0.94%

PTIXW -5.10%

PULM 2.63%

PXMD -4.59%

PYPD 0.07%

PYXS -4.08%

QLGN -6.58%

QNCX -2.48%

QNRX -4.84%

QSI -2.50%

QSIAW -3.13%

QTTB -3.97%

QURE -1.76%

RAIN -1.63%

RANI -9.00%

RAPT -4.94%

RARE 1.09%

RCKT -0.87%

REGN 0.69%

RENB 1.26%

REPL 0.68%

RETA 0.02%

REUN -0.89%

REVB -10.42%

REVBU 3.46%

REVBW -38.46%

RGLS 4.39%

RGNX -3.67%

RIGL -11.87%

RLAY -2.32%

RLMD -0.33%

RLYB -3.25%

RNA -1.79%

RNAC 4.43%

RNAZ 1.96%

RNXT -1.74%

ROIV -0.73%

ROIVW 4.56%

RPHM -0.62%

RPRX -0.77%

RPTX -3.67%

RUBY 2.70%

RVLP -32.05%

RVMD 0.86%

RVMDW 5.10%

RVNC -8.56%

RVPH -1.56%

RVPHW -3.43%

RXDX 0.09%

RXRX 0.43%

RYTM 0.52%

RYZB 0.02%

RZLT -9.15%

SABS 0.00%

SABSW 0.25%

SAGE -5.71%

SANA -2.17%

SAVA -2.58%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI -8.04%

SCPH -2.94%

SCPS 0.00%

SEEL 2.13%

SEER -1.73%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -4.94%

SGMT -1.43%

SGTX -2.56%

SIOX 22.63%

SLDB -12.39%

SLGL 8.36%

SLN -2.01%

SLNO -2.84%

SLRX 1.24%

SLS -3.31%

SMMT 0.13%

SNDX -1.31%

SNGX -21.60%

SNPX -3.13%

SONN -0.33%

SPPI -0.49%

SPRB 3.68%

SPRC -2.37%

SPRO 0.00%

SRNE -9.09%

SRPT -3.53%

SRRA 0.00%

SRRK -4.04%

SRZN -2.45%

STAB 0.00%

STOK -2.65%

STRO -2.61%

STSA 0.00%

STTK -10.11%

SURF -0.93%

SVRA 3.83%

SWTX 0.94%

SYBX 1.97%

SYRS -0.17%

TALS -0.73%

TARA -5.83%

TARS -2.36%

TBPH -4.22%

TCBP -9.85%

TCDA 0.00%

TCON 21.14%

TCRR 0.00%

TCRT -3.63%

TCRX -7.47%

TECH -1.91%

TENX 3.88%

TERN -3.59%

TFFP 3.68%

TGTX 4.24%

THRX 0.12%

TIL 0.00%

TLC 0.00%

TLSA 2.32%

TNGX -8.77%

TNXP 5.04%

TNYA -7.61%

TPST -1.44%

TRDA 3.72%

TRVI -1.14%

TRVN -2.41%

TSHA -7.33%

TSVT -2.59%

TTNP -0.91%

TVTX 2.18%

TYRA -0.88%

UBX 0.36%

UNCY -26.76%

URGN -5.61%

UTHR 0.03%

VACC 11.36%

VALN -4.35%

VAXX -5.88%

VBIV 3.23%

VBLT -8.77%

VCEL -2.81%

VCNX -6.47%

VCYT -0.92%

VERA 0.97%

VERU -6.67%

VERV -0.95%

VIGL -4.12%

VINC -3.01%

VIR 0.66%

VIRI -5.96%

VIRX -3.22%

VKTX -8.29%

VLON -13.04%

VNDA 2.68%

VOR 0.00%

VRCA -0.98%

VRDN -3.41%

VRNA -4.14%

VRPX -2.58%

VRTX -0.24%

VSTM -5.16%

VTGN 2.79%

VTVT -6.43%

VTYX -4.02%

VXRT -7.63%

VYGR -2.92%

VYNE 0.00%

VYNT 7.78%

WINT -3.24%

WVE -8.45%

XBIO -8.15%

XBIT 5.73%

XCUR -4.08%

XENE -1.10%

XERS -0.47%

XFOR -4.95%

XLO -3.30%

XLRN 0.00%

XNCR -3.68%

XOMA -5.07%

XOMAO 0.36%

XOMAP 0.73%

XRTX -3.29%

YMAB 1.16%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -1.23%

ZNTL -8.70%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2022-02-10	Aberman Zami	Buy	80 616	Common Stock
2021-05-26	Clover Wolf Capital - Limited Partnership	Sell	122 663	Common Stock
2021-05-26	Clover Wolf Capital - Limited Partnership	Sell	22 015	Common Stock
2021-05-27	Clover Wolf Capital - Limited Partnership	Sell	71 775	Common stock
2021-05-27	Clover Wolf Capital - Limited Partnership	Sell	24 110	Common stock

INSIDER POWER
0.00
Last 98 transactions
Buy: 11 245 290 \| Sell: 1 084 851

Volumen Korrelation

Lang: 0.39 (neutral)

Kurz: -0.82 (strong negative)

Signal:(32.85) Neutral

Pluristem Therapeutics Korrelation

10 Am meisten positiv korreliert

10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Pluristem Therapeutics Korrelation - Währung/Rohstoff

-0.50
( neutral )

0.83
( strong )

0.00
( neutral )

-0.36
( neutral )

0.00
( neutral )

0.85
( strong )

Pluristem Therapeutics Finanzdaten

Annual	2021
Umsatz:	$0.00
Bruttogewinn:	$0.00 (0.00 %)
EPS:	$-1.770

FY	2021
Umsatz:	$0.00
Bruttogewinn:	$0.00 (0.00 %)
EPS:	$-1.770

FY	2020
Umsatz:	$23 000.00
Bruttogewinn:	$23 000.00 (100.00 %)
EPS:	$-1.600

FY	2019
Umsatz:	$54 000.00
Bruttogewinn:	$52 000.00 (96.30 %)
EPS:	$-2.90

Financial Reports:

No articles found.

Pluristem Therapeutics Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Pluristem Therapeutics

Pluristem Therapeutics Inc. operates as a bio-technology company. It focuses on the research, development, clinical trial, and manufacture of cell therapeutic products and related technologies for the treatment of various ischemic, inflammatory, and hematologic conditions, as well as autoimmune disorders. The company develops placental expanded (PLX) based cell therapy products, including PLX-PAD that is in Phase III clinical trial for the recovery after surgery for hip fracture; in Phase II clinical trail for the treatment of acute respiratory distress syndrome associated with COVID-19; and in Phase I/II clinical trial for treatment of steroid-refractory graft versus host disease. It also develops PLX-R18, which has completed Phase I clinical trial incomplete hematopoietic recovery following hematopoietic cell transplantation, as well as conducts various animal studies for the evaluation of PLX-R18 for the treatment of acute radiation syndrome. The company has a license agreement for conducting clinical trials of PLX-PAD product in South Korea. It also has a collaborative project nTRACK, that examines gold nano particles labeling of stem cells; and has collaboration agreement with the NASA\'s Ames Research Center to evaluate the potential of PLX cell therapies in preventing and treating medical conditions caused during space missions. Pluristem Therapeutics Inc. was incorporated in 2001 and is based in Haifa, Israel.